Delivery Order SPE2DB22D3102-SPE2DB24FL1MX
Award Date
6/4/24
Potential Completion Date
6/5/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $25,226.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,389,606 tablets of the medication Glipizide ER 10 mg, a treatment for diabetes. This is a firm fixed-price delivery order contract with an ultimate completion date of April 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,665.88 delivery order is for the supply of 4,565,176,341 units of Glipizide ER 10 mg tablets, a medication used to manage diabetes. The contract has a firm fixed price and an ultimate completion date of July 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,814.40 firm-fixed-price delivery order is for the supply of 4,564,895,994 glipizide ER 10 mg tablets. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a leading pharmaceutical distributor. The $3,675.32 Firm Fixed Price delivery order is for the supply of 4,564,836,203 Glipizide ER 10 mg tablets. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department...
This is a firm fixed-price delivery order under contract SPE2DX15D1205 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,509.18 award is for 1,000 tablets of Glipizide ER 10 mg, a medication used to treat diabetes. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract with the DLA, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,930.77, is for the delivery of Glipizide ER 2.5 mg tablets, a medication used to manage diabetes. The contract is a Firm Fixed Price Delivery Order, with a period of performance through March 7, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,559 units of the pharmaceutical product Glipizide ER 10 mg tablets. The $4,974.55 Firm Fixed Price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,731.54 firm-fixed-price delivery order is for the supply of 4,565,110,089 units of Glipizide ER 10 mg tablets, with a completion date of July 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $11,911.01 firm-fixed-price delivery order is for the supply of 4,565,266 units of Glipizide Extended Release 10 mg Tablets in 500-count bottles. The contract has an ultimate completion date of July 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous indefinite delivery contracts (IDCs) with the...
This federal contract award is for the delivery of 1,000 units of the pharmaceutical product Glipizide ER 10 mg tablet to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,621.83 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation located in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp serves as a prime contractor providing a range of pharmaceutical products and medical supplies to the...